For 30 advance/early chapters : p atreon.com/AutumnXd
The launch was a comprehensive success.
By the time the fitting center closed for the night, more than two thousand visitors had passed through. Every corner of the building had hosted a person, a conversation, a question. The five-story building had been operating at full capacity for twelve consecutive hours.
The showcase galleries had moved more volume. Across twelve domestic cities, total visitor count cleared a hundred thousand by end of day. Mall traffic at the gallery locations spiked to numbers that mall managers compared to Black Friday levels. Many visitors weren't candidates for prosthetics at all. They were curious civilians who had watched the livestream and wanted to see the technology in person.
That was the secret of Triton-1's market reception. The product's target audience was people who needed prosthetics. The product's actual audience was anyone who had ever fantasized about controlling a robot arm with their mind. Cybernetics fantasies had been part of popular culture for decades. Triton-1 was the first product that delivered on the fantasy. The result was that the prosthetic broke out of its niche and became a mainstream cultural moment.
Online engagement reflected the broader interest. The launch was the dominant story across every major platform. Television coverage was extensive. NPBN's evening news led with Erik Donovan's coverage, integrating his footage and analysis into the network's flagship broadcast. Other networks followed with their own variations on the theme.
The same television program that had hosted Alcott weeks earlier reached out to invite him for another segment. Alcott declined. He was busy. He was on the phone with NeuraPath's investors trying to keep them from triggering breach-of-contract clauses.
NeuraPath's investors had committed real money to a company whose competitive position had just been obliterated. They wanted explanations. They wanted reassurances. Some of them wanted out. Alcott spent the entire afternoon and evening on calls trying to keep the company's funding intact.
Eventually he carved out time in the late evening to watch Helios's launch.
Helios's Angel launch event began at one p.m. Eastern.
Reeve was on stage, addressing an auditorium-style theater filled with reporters and industry analysts. The lighting was theatrical: dimmed house, bright stage spotlights, presentation screen behind him glowing. The format was the conventional product launch theater that Reeve had originally chosen as a power statement.
The contrast with Triton-1's tea-party launch could not have been starker.
Whitfield joined Reeve onstage to discuss the technical aspects. The professor's enthusiasm was visibly forced. His voice carried the determined flatness of someone reciting prepared remarks.
The Angel product had legitimate features. The most genuinely impressive was tactile feedback. Microscopic sensors integrated into the prosthetic's fingertips relayed pressure, temperature, and texture data through the surgically transplanted nerves to the user's somatosensory cortex. Users with Angel could feel objects they touched. The sensation wasn't biological-equivalent, but it was real and useful.
Reeve and Whitfield emphasized this feature throughout the presentation. Tactile feedback was Angel's strongest single advantage over Triton-1. The pitch was that Angel was not just a prosthetic, it was a return of sensation, a more complete restoration of the lost limb's function.
The argument was real. The audience could see why it mattered.
But there were problems.
Angel was heavier than Triton-1. It used more power and had shorter battery life. Its cosmetic appearance, while polished, lacked Triton-1's distinctive visual signature. And it required surgery.
Then a reporter asked the price question.
Reeve had not wanted to disclose the price. He'd hoped to defer the conversation to private consultation. But the reporters pushed. He couldn't avoid it without making the avoidance itself a story.
"The starting price for Angel," he said, "is approximately eighty thousand dollars. Final pricing depends on the patient's specific configuration and surgical requirements."
The audience reaction was visible.
Eighty thousand dollars. Almost three and a half times Triton-1's maximum. And Reeve had used the word "starting," which meant most patients would pay more.
Several reporters wrote the price down without further questions. The headline would be the price. The launch was, in effect, over.
Across the country, Tom and Ryan watched Helios's launch from the family living room.
When tactile feedback was demonstrated, Tom's expression tightened. The capability was a real advantage. If Angel could deliver a return of touch, that might preserve a market segment for the surgical approach.
Then Reeve disclosed the price. Tom's expression relaxed completely.
"We're fine."
Eighty thousand dollars was simply too much. Even in premium markets, the audience for an eighty-thousand-dollar prosthetic was orders of magnitude smaller than the audience for a twenty-three-thousand-dollar prosthetic. The tactile feedback advantage was real, but it wasn't a multiple-of-three-and-a-half advantage.
Helios was effectively withdrawing from the mass market by pricing.
Ryan didn't really care about the launch. He was watching his system display.
Project Two: 89%.
Eight hundred million people had heard the words "Triton-1" or "Mercer" in the past twenty-four hours. The Summon Points were arriving at an unprecedented rate. The progress bar was climbing toward completion fast enough that he could practically watch it move.
The doorbell rang.
The visitor was Eric Hudson, the operations lead Tom had hired to run the flagship fitting center. Hudson was forty, formerly the manager of a state-owned prosthetics facility, with two decades of operational experience in the industry. Tom had recruited him personally. He carried a leather portfolio and looked exhausted.
Hudson came in, exchanged greetings, glanced briefly at the security setup he'd had to clear at the front gate, and sat down across from Tom and Ryan.
"Mr. Mercer. I came to give you the day-one operations report. The fitting center just closed."
"I was about to call you," Tom said, muting the Helios broadcast. "Walk us through the numbers."
Hudson opened his portfolio and produced a printed report. Tom flipped through the data.
"Thirty-seven prosthetists active today. Average of approximately seventy patient consultations per fitter. Total firm orders confirmed: one hundred and thirty-three. Most of the remaining consultations were patients who indicated interest but wanted to think about it or were waiting on financing approval."
"Those numbers are exceptional," Tom said. "I'm proud of the team. Make sure the fitters know that. The socket fabrication is the most patient-impacting part of the install. They need to take pride in the quality of that work."
"Frank Bauer is leading the technique training. He's making sure every fitter is up to his standards."
Ryan picked up a copy of the report and scanned the totals.
One hundred and thirty-three confirmed orders. Average install price hovering around fifteen thousand dollars (well below the twenty-three thousand maximum). Total day-one revenue: approximately two million dollars.
This had probably tapped the pent-up demand from the immediate-launch crowd. Future order flow would stabilize at a lower rate as the market saturated and patients took longer to make decisions. But the day-one number established the baseline.
"How are the international preparations?"
Hudson had been managing that workstream too.
"I retained a regulatory consulting firm to handle the international filings. The process has been straightforward so far, no obstacles. I expect our first international fitting center to open in mid-January."
"Decent timeline," Ryan said. Even with the delay, Triton-1 would reach international markets before Helios's surgical alternative could displace the comparative narrative. The mass-market positioning would hold.
The three of them discussed expansion plans for another thirty minutes. Hudson outlined the staffing and operational requirements for international rollout. Tom discussed financing options for facility expansion. Ryan listened more than he talked. The operational details were Tom's domain. He'd hired good people for a reason.
Around two thirty in the morning, Hudson left to get some sleep. Tom and Lisa headed to bed soon after. The Helios broadcast was wrapping up on the television, its anchor speaking with the deliberate tone of a presenter trying to manage a launch that hadn't gone according to plan.
Ryan stayed up a little longer, reading through Hudson's report and thinking.
Triton-1 was launched. The market position was secured. The international rollout was on track. Tom had the operations under control. The company would handle itself for the next several weeks without daily input from Ryan.
Which meant Ryan could go back to the work that had been waiting for him.
He stretched, packed a bag, and booked a flight back to the coast for the next morning.
There was a seventy-ton arm waiting for him at Dome Base, and he was eager to start putting it together.